Infographic: Asia’s Pharma Market Values by Country 19 July 2012 / By YuenLing / Partnering & Investment / 0 comments
Supply Chain: In-house or Out-source? 6 July 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
Costly Protocols Unnecessary? How much you gain by cutting them out of your clinical development 5 July 2012 / By YuenLing / Clinical Trials, Drug Safety, Regulation and Government, Reports / 1 comment
What is needed is a little authoritative push for pharma supply chains. 28 June 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
The New Age Where Supply Chain Matters Much. 25 June 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
FDA discovers counterfeits under international pharmaceuticals 15 June 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
With the new User Fee Bill, safer overseas supply chain can be made possible. 31 May 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
India Industry wants govt to enforce SCM standards for dry pharma products 17 May 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
In an era of patent expiry and global outsourcing, Pharma needs to rethink supply chain 27 March 2012 / By YuenLing / Supply Chain & Manufacturing / 0 comments
Tectonic Transformations: “The future of Biopharmaceuticals in Asia” – Quintiles 22 March 2012 / By YuenLing / Clinical Trials / 0 comments
